Related Experiment Video
Updated: Jan 4, 2026

08:35
Elastomeric PGS Scaffolds in Arterial Tissue Engineering
Published on: April 8, 2011
16.0K
Small Diameter Xenogeneic Extracellular Matrix Scaffolds for Vascular Applications
Manuela Lopera Higuita1, Leigh G Griffiths2
1Mayo Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, Minnesota.
Tissue Engineering. Part B, Reviews
|October 31, 2019
Summary
Coronary artery bypass graft (CABG) surgery faces challenges with autologous vessels. Xenogeneic extracellular matrix (ECM) scaffolds offer a promising alternative, but overcoming their failure mechanisms is key for successful CABG.
Area of Science:
- Biomaterials Science
- Cardiovascular Surgery
- Tissue Engineering
Background:
- Coronary artery bypass graft (CABG) surgery commonly uses autologous vessels, but harvest complications and limited availability hinder success.
- Acellular extracellular matrix (ECM) scaffolds from xenogeneic sources offer an "off-the-shelf" solution with greater availability for CABG.
Purpose of the Study:
- To review the failure mechanisms of current small-diameter xenogeneic ECM scaffolds for CABG.
- To highlight recent advances in overcoming these failure mechanisms for improved graft patency.
Main Methods:
- Literature review of xenogeneic ECM scaffold research for CABG.
- Analysis of identified failure mechanisms in small-diameter vascular grafts.
- Synthesis of recent advancements in scaffold development.
Main Results:
- Current xenogeneic ECM scaffolds face multiple failure mechanisms that prevent full functionality.
- Significant research efforts are underway to address these limitations.
- Overcoming these challenges is crucial for developing effective ECM-based CABG grafts.
Conclusions:
- Developing functional small-diameter xenogeneic ECM scaffolds for CABG requires overcoming specific failure mechanisms.
- Continued research into biomaterial modifications and tissue engineering strategies is essential.
- Successful development promises to improve CABG outcomes by eliminating autologous graft complications.

